Related Experiment Video
Updated: Feb 27, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Chronic constipation in Rome IV era: The Indian perspective.
1Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India. udayghoshal@gmail.com.
Chronic constipation (CC) in India presents unique challenges compared to Western populations. Functional constipation (FC) is more prevalent than IBS-C, with limited non-pharmacological treatment options available.
Area of Science:
- Gastroenterology
- Internal Medicine
- Public Health
Background:
- Chronic constipation (CC) is a global health issue with distinct characteristics in India.
- The Rome IV guidelines have spurred interest in the Indian perspective on CC.
- Differences exist in bowel habits, epidemiology, pathophysiology, and management compared to Western countries.
Purpose of the Study:
- To review chronic constipation in India, highlighting unique aspects.
- To discuss the differences in CC definition, epidemiology, and pathophysiology in India.
- To explore current management strategies and unmet needs for CC in India.
Main Methods:
- Literature review focusing on chronic constipation in the Indian context.
- Analysis of differences in CC presentation and pathophysiology between India and the West.
- Examination of current diagnostic and management approaches, including pharmacological and non-pharmacological options.
Main Results:
- Functional constipation (FC) is more common than constipation-predominant irritable bowel syndrome (IBS-C) in India, partly due to less frequent abdominal pain.
- Pathophysiological mechanisms include slow colon transit and fecal evacuation disorder (FED), but lifestyle factors are significant in primary care.
- Non-pharmacological management for FED, like biofeedback, has limited availability in India.
Conclusions:
- Chronic constipation in India requires a tailored approach considering unique epidemiological and pathophysiological factors.
- There is a need for improved access to diagnostic tools and non-pharmacological treatments for CC, particularly FED.
- Addressing lifestyle and dietary factors is crucial for managing CC in the Indian primary care setting.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

